Ludwig Institute for Cancer Research

Ludwig Institute for Cancer Research

I am persuaded that eventual mastery of cancer will only come from intense and unremitting scientific exploration over many decades - Daniel K. Ludwig. December 17, 1974.

The Ludwig Institute for Cancer Research Ltd (LICR)is a global non profit committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for human benefit.

Read More >

LICR Investigators

Dr. Webster K. Cavenee

The ground-breaking research of Dr. Webster (Web) Cavenee, Director of the LICR’s San Diego Branch, helped alter the way scientists view the onset and progression of cancer. Dr. Cavenee’s discovery of the genetic lesions in retinoblastoma resulted in the first indisputable evidence for the existence of tumor suppressor genes in human cancer. Mutations in tumor suppressor genes have now been identified in more than 50% of all cancers. For his contributions thus far, Dr. Cavenee has received multiple accolades and awards.